Danazol in the management of ureteral obstruction secondary to endometriosis

case-report OA: closed public-domain-us ⤵ 1 in-corpus citation
View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Danazol treatment showed no regression of ureteral obstruction due to dense fibrotic endometriosis in one patient, indicating its limited effectiveness once fibrosis has occurred.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ureteral obstruction caused by endometriosis is uncommon. It is, however, an important complication that imposes a 25% chance for permanent loss of renal function on the affected side. The standard management is surgical; however, three cases have been reported in which regression of obstruction followed medical therapy. This case report concerns a patient with long-standing partial ureteric obstruction due to endometriosis who was treated for 2 months with danazol. Clinical response of the endometriosis was excellent, but the obstruction persisted, a retroperitoneal ureteroneocystotomy was therefore performed. The ureter was found to be obstructed by dense fibrous tissue that contained endometrial glands. It seems therefore that a trial of danazol may be attempted in selected cases, but that the drug is unlikely to relieve endometriotic ureteric obstruction once dense fibrosis has occurred.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Pregnadienes Ureteral Neoplasms Ureteral Obstruction Adult Danazol Endometriosis Endometriosis Female Humans Pregnadienes Ureteral Neoplasms Ureteral Obstruction

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-05-13T22:09:45.632124+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine